October 21, 2019

IntegriChain Access Insights Conference Breaks Attendance Records

Bio/Pharma Market Access, Trade, Patient and Finance Teams Converge for Three-Day Event Focused on Data-Driven Strategies to Save Patient Days of Therapy

Philadelphia, PA, October 21, 2019– IntegriChain, a leading life sciences commercial data and analytics company that helps patients start therapy faster and stay on therapy longer, today announced that its annual Access Insights Conference (formerly the IntegriChain User Conference) broke attendance records with more than 190 participants, including seven ecosystem partners and sponsors and more than 25 industry speakers. The three-day conference, beginning today in Atlanta/Buckhead, attracts bio/pharma brand and access teams, including those focused on Contracts & Pricing, Gross-to-Net, Finance, Patient Services, Field Reimbursement, Data Management & Analytics, Trade & Channel, and Commercial Operations from leading and emerging manufacturers.

“We are excited to evolve our Access Insights Conference to deliver even more thought leadership, benchmark data, and industry insights to such a wide audience of bio/pharma executives and professionals – from traditional Big Pharma to emerging biotechs and cell and gene therapy pioneers,” said Kevin Leininger, Co-Founder and CEO of IntegriChain. “Our goal is to help manufacturers develop and execute commercialization and access strategies based on the actionable data and the leading-edge data science we deliver. We will demonstrate how to capitalize on the power of data refining, AI/ML innovation, automation, and scheduled reporting, enabling market access and commercialization teams to scale as they rapidly grow and mature.”

“We thank all our customers for joining us this week in Atlanta and for forging a deep and meaningful partnership to help patients start and stay on therapy,” said Co-Founder and EVP of IntegriChain, Josh Halpern. “We also thank our sponsors and ecosystem partners for supporting our conference and for delivering an expanded set of access insights to our industry attendees.”

The Access Insights Conference kicks off today with the Executive Summit, delivering thought leadership, benchmark data, and high-value industry panels focused on strategies to drive pharmaceutical commercialization and access. Beginning on Day 2, more industry speakers and subject matter experts take the podium for dozens of topic track sessions focused on utilizing data and analytics to overcome commercialization and access challenges. The conference also includes a pre-conference event, the Revenue Analytics Collaborative Summit, for those in Pricing & Contracting, Rebate & Chargeback Management, GTN, and Trade & Channel for roundtable discussions, benchmarking, and networking.

Conference Ecosystem Partners
The Access Insights Conference is sponsored by Mirador Analytics, PwC, TrialCard, and Two Labs Pharma Services and is supported by the following IntegriChain ecosystem partners: CareMetx, Crossix, and EVERSANA.

About IntegriChain
IntegriChain is a life sciences commercial data and analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence. Our mission is to help all stakeholders in pharmaceutical access save as many patient days of therapy as possible. Our data-science-driven ICyte Platform and solutions uniquely focus on access challenges after the patient and provider commit to therapy. More than 165 life science manufacturers rely on insights delivered from IntegriChain’s data, analytics, and managed services to drive strategic decision-making and on-going business management across their payers, specialty pharmacies, patient services, and distribution channel partners. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, and Pune, India. For more information, visit and our blog, or follow us on Twitter @IntegriChain and LinkedIn.

Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 |

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article